QEH DRUGS ‘SOON’
THE QUEEN ELIZABETH HOSPITAL (QEH) will this week address the shortage of critical drugs withheld by suppliers because of non-payment, the chief executive said last night.
The pay issue will be tackled soon, Dr Dexter James told the SUNDAY?SUN when asked to respond to information received by this newspaper indicating that 76 drugs – some of them required for cancer treatment, kidney and pulmonary diseases – were out of stock.
According to the stock list prepared by the drug and therapeutic committee at the QEH, 46 drugs were being withheld by suppliers because of arrears.
The list includes Seretide, which is used in chronic obstructive pulmonary disease, chemotherapy drugs or drugs used for cancer treatment such as Xeloda, Kytril and Tamulosin, and eye medications, including Systane, Saflutan and Cosopt.